https://www.selleckchem.com/pr....oducts/msc2530818.ht
Experiencing hypoglycaemia was associated with increased HFS-II worry and overall scores. Conclusions Our results highlight the global inequity in the treatment of type 2 diabetes. Increased risk of hypoglycaemia in middle-income countries may be explained by limited treatment options and may be underestimated because of limited access to glucose-monitoring equipment.Aim To describe the clinical characteristics and outcomes of hospitalized COVID-19 patients with diabetes. Methods A retrospective cross-sectional study was conducted am
Like
Comment
Share
